Jerusalem- A team of researchers has found that cannabis therapy may help reduce blood pressure (BP) in older adults.
The study, published in the European Journal of Internal Medicine, found a significant reduction in 24-hour systolic and diastolic blood pressure values, with the lowest point occurring three hours after ingesting cannabis either orally via oil extracts or by smoking.
"Older adults are the fastest growing group of medical cannabis users, yet evidence on cardiovascular safety for this population is scarce," said researcher Ran Abuhasira from the Ben-Gurion University of the Negev in Israel.
"This study is part of our ongoing effort to provide clinical research on the actual physiological effects of cannabis over time," Abuhasira added.
For the study, the research team evaluated 26 patients aged 60 years or more with hypertension and a new prescription of cannabis.
The team performed the following assessments -- 24-hours ambulatory blood pressure monitoring, ECG, blood tests, and anthropometric measurements prior to the initiation of cannabis therapy and 3 months both before and three months after initiating cannabis therapy.
Among older adults with hypertension, cannabis treatment for three months was associated with a reduction in 24-hours systolic and diastolic blood pressure values with a nadir at 3 hours after cannabis administration, the study said.
The research team theorize that the relief from pain, the indication for prescription cannabis in most patients, may also have contributed to a reduction in blood pressure.
"Cannabis research is in its early stages and BGU is at the forefront of evaluating clinical use based on scientific studies," said researcher Doug Seserman from the varsity. (Agency)
London, Jan 29 (IANS) Adolescents who frequently use cannabis may experience a decline in Intelligence Quotient (IQ) over time, a new study suggests.The findings, published in the journal Psychological Medicine, revealed that there were declines of approximately 2 IQ points over time in those who use cannabis frequently compared to those who didn't use cannabis. Further analysis suggested that this decline in IQ points was primarily related to reduction in verbal IQ."Cannabis use during youth is of great concern as the developing brain may be particularly susceptible to harm during this period," said researcher Emmet Power from the Royal College of Surgeons in Ireland (RCSI)."The findings of this study help us to further understand this important public health issue," Power added.For the study, the team involved systematic review and statistical analysis on seven longitudinal studies involving 808 young people who used cannabis at least weekly for a minimum of 6 months and 5308 young people who did not use cannabis. In order to be included in the analysis each study had to have a baseline IQ score prior to starting cannabis use and another IQ score at follow-up. The young people were followed up until age 18 on average although one study followed the young people until age 38."Previous research tells us that young people who use cannabis frequently have worse outcomes in life than their peers and are at increased risk for serious mental illnesses like schizophrenia," said researcher Mary Cannon, Professor at RCSI."Loss of IQ points early in life could have significant effects on performance in school and college and later employment prospects," Cannon added.--IANSvc/sdr/
As per a study published in the 'British Medical Journal', menstrual pain, heavy bleeding and low mood may be linked to nearly nine days of lost productivity per woman every year. A focus group study indicates that 84.1 per cent women reported the occurrence of menstrual cramps or primary dysmenorrhea during their menstrual cycles.
Periods are usually associated with mild, tolerable lower abdomen or back discomfort but the pain (dysmenorrhoea) can be severe enough to interfere with day-to-day activities. The existing solutions in modern healthcare and allopathic medicine system are known to have harmful side effects in long term.
In its endeavour to offer a more sustainable, herbal and ayurvedic solution for medical cramps, India's first research to retail venture in the Ayurvedic Cannabis (Bhang) sector, HempStreet has announced the launch of medicinal cannabis based Trailokya Vijaya Vati.
The medicine has cannabis as one of its key ingredients and is effective in soft tissue muscle pains like menstrual cramps and spasms.
Shrey Jain, Co-Founder at HempStreet says: "Menstruation as a topic is highly stigmatised in our country. Period pain is often ignored by making a significant part of women lifestyle and working hours stressful and painful. But the fact is that women have even described the cramping pain as 'almost as bad as having a heart attack'. On an average, a woman goes through around 450 menstrual cycles throughout her lifetime. Irony is that the available solutions in modern medical science possess threat of serious harmful effects in case of long term consumption. Trailokya Vijaya Vati aims at providing a reliable, safe and ayurvedic solution to the women of 21st century.
He adds: "Hempstreet is working in conjunction with top notch scientists to conduct R&D around safe medication by leveraging the immense potential and natural power of Cannabis. Today HempStreet boasts of 15 approved products and a world-class research partnership with Council of Scientific and Industrial Research (CSIR). We have successfully reached out to extensive doctor network of 43,000 doctors and 230 clinics to provide medical cannabis medicine, primarily to alleviate the huge menstrual pain relief crisis in India. The company strive to bring an effective and responsible usage of Cannabis, especially on the pain relief front, to its potential addressable patient base of over 35 million individuals."
The Cannabis Sativa plant, which encompasses hemp, cannabis, and marijuana, contains more than 100 different chemicals called cannabinoids. These are used to treat many diseases and conditions, including chronic pain, insomnia, anxiety, menstrual cramps, muscle spasms, mental health, epilepsy, and multiple sclerosis, sexual disorders, and more. The legal Cannabis industry is currently one of the fastest growing industries in the world. According to a report by Grand View Research Inc., the global legal marijuana market is predicted to reach $146.4 billion by the end of 2025.
(Puja Gupta can be contacted at [email protected])
New York, Jan 9 (IANS) More than half of people who use medical marijuana products to ease pain also experience clusters of multiple withdrawal symptoms when they're between uses, a new study finds.The findings also indicated that about 10 per cent of the patients taking part in the study experienced worsening changes to their sleep, mood, mental state, energy and appetite over the next two years as they continued to use cannabis."Some people report experiencing significant benefits from medical cannabis, but our findings suggest a real need to increase awareness about the signs of withdrawal symptoms developing to decrease the potential downsides of cannabis use, especially among those who experience severe or worsening symptoms over time," said lead researcher Lara Coughlin from the University of Michigan.Many of them may not recognize that these symptoms come not from their underlying condition, but from their brain and body's reaction to the absence of substances in the cannabis products they're smoking, vaping, eating or applying to their skin, the researcher said.For the study, published in the journal Addiction, the team involved of 527 participants. All were participating in the state's system to certify people with certain conditions for use of medical cannabis and had non-cancer-related pain.The researchers asked the patients whether they had experienced any of 15 different symptoms - ranging from trouble sleeping and nausea to irritability and aggression - when they had gone a significant time without using cannabis.The researchers used an analytic method to empirically group the patients into those who had no symptoms or mild symptoms at the start of the study, those who had moderate symptoms (meaning they experienced multiple withdrawal symptoms) and those who had severe withdrawal issues that included most or all of the symptoms.They then looked at how things changed over time, surveying the patients one year and two years after their first survey.Further research could help identify those most at risk of developing problems, and reduce the risk of progression to cannabis use disorder, which is when someone uses cannabis repeatedly despite major impacts on their lives and ability to function, the researcher said.--IANSvc/sdr/
भांग के औषधीय गुणों का लोहा अब संयुक्त राष्ट्र संघ ने भी मान लिया है. एक ऐतिहासिक फैसले के तहत संयुक्त राष्ट्र संघ ने भांग को खतरनाक मादक पदार्थों की सूची से बाहर करके इसे औषधि के रूप में मान्यता दे दी है.
गौरतलब है कि पिछले चार दशकों से भांग प्रतिबंधित सूची में था. लेकिन अंततः विश्व स्वास्थ्य संगठन (डब्ल्यूएचओ) की सिफारिश पर भांग को दवा के रूप में मान्यता दे दी गयी.
इस सम्बन्ध में संयुक्त राष्ट्र संघ के कमीशन ऑफ नारकोटिक ड्रग्स के 63वें सालाना सेशन में वोटिंग हुई जिसमें पक्ष में 27 वोट पड़े जबकि 25 सदस्य देशों ने इसके विपक्ष में वोट दिया. भारत ने इसके पक्ष में मतदान किया.
आयुर्वेद के ग्रंथों में भांग के औषधीय गुणों का वर्णन मिलता है और इसका प्रयोग लम्बे समय से होता आया है.
लेकिन पिछले काफी समय से प्रतिबन्ध की वजह से इसपर रिसर्च आदि नहीं हो पा रहे थे, साथ ही औषधि के रूप में इसके प्रयोग करने में भी कई तरह की बाधाएं थी.
यूएन से अब मान्यता मिलने के बाद इसके औषधीय प्रयोग को और बल मिलेगा.
यह भी पढ़े - भांग से कोरोना की दवा बनाने का कनाडा की कंपनी का दावा
भांग (Cannabis) से कैंसर (Cancer) का इलाज (Treatment)
भांग (Cannabis) के उत्पादन और बिक्री को वैध बनाने के लिए नेपाली संसद में बिल पंजीकृत
कनाडा की एक कंपनी ने भांग (cannabis) से कोरोनावायरस (coronavirus) की दवा बनाने का दावा किया है. कंपनी का कहना है कि इस दवा का कोई साइड इफेक्ट नहीं होता और कोरोना वायरस की वजह से होने वाले दिल संबंधी बीमारियों से भी ये बचाएगी. भारत में इसके ट्रायल के लिए दवा बनाने वाली कंपनी सरकार से बातचीत कर रही है.
अकसीरा दवा कंपनी की कोरोना के लिए बनाई गई दवा का नाम कैनाबिडियोल (Cannabidiol - CBD) है. दवा कंपनी का दावा है कि उनकी दवा कई तरह की बीमारियों का इलाज कर रही है. जैसे तेज दर्द का इलाज करता है. कीमोथैरेपी के होने वाले साइड इफेक्ट्स को कम करता है. इसमें एंटीवायरल खूबियां भी हैं. इसलिए कंपनी का दावा है कि यह कोरोना वायरस का इलाज भी कर देगी.
अकसीरा कंपनी का दावा है कि कैनाबिडियोल (Cannabidiol - CBD) दवा की वजह से दिल की कोशिकाओं में एरिथमिया (Arrhythmia) बीमारी का असर नहीं होता. इसके साथ ही वह हाई-ग्लूकोज की वजह से होने वाली दिक्कतों को भी कम कर देता है. इस दवा की मेडिकल रिपोर्ट हाल ही में ब्रिटिश जर्नल ऑफ फार्मैकोलॉजी में प्रकाशित हुई है.
कोरोना वायरस से संक्रमित लोगों को दिल संबंधी एक बीमारी होती है, जिसे एरिथमिया कहते हैं. इस बीमारी में दिल की बीट्स यानी धड़कन सही से नहीं चलती. कभी तेज कभी धीमी चलती है. जबकि, आमतौर पर दिल की धड़कन एक सामान्य फ्लो में चलती है.
दिल में एरिथमिया (Arrhythmia) तब होता है जब दिल में जाने वाली इलेक्ट्रिकल इंपल्सेस (Electrical Impulses) सही से काम नहीं करती हैं. अगर इसकी सही समय पर जांच न की जाए तो इससे दिल का दौरा पड़ने की आशंका रहती है. या फिर दिल संबंधी अन्य गंभीर बीमारियां हो सकती हैं.
( स्रोत - आजतक)